Mariano P. S.
- Country
- Spain
- Department
- Oncology department
Research Overview
- Phase 1b Study of OMTX705 in Patients with Advanced/Metastatic Pancreatic Adenocarcinoma
- Safety and Efficacy of RO7673396 Monotherapy and Combination Therapy in Patients with Advanced RAS-Mutant Solid Tumors
- A Phase 1 Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with KRAS G12D-Mutated Advanced Solid Tumors
Data & Insights
Has run more than one trial at 210 of 431 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular emphasis on cases involving specific genetic mutations.
- EGFR Mutations and Exon20 Insertions
- KRAS G12C Mutations
- PD-L1 Expression Patterns
Their research encompasses both early-stage and metastatic disease states, focusing on novel therapeutic approaches for various NSCLC subtypes.
Immunotherapy Innovation
The investigator explores innovative immunotherapy combinations and targeted treatments for cancer patients, particularly focusing on:
- Novel Immunotherapy Combinations
- Neoadjuvant Treatment Approaches
- Targeted Molecular Therapies
Their work includes evaluation of combination therapies with established treatments like pembrolizumab.
Head and Neck Cancer
The investigator conducts research in head and neck squamous cell carcinoma (HNSCC), with a focus on:
- Locoregionally Advanced Disease
- Recurrent/Metastatic HNSCC
- Novel Treatment Combinations
Their work includes investigation of innovative therapeutic approaches for both early-stage and advanced HNSCC.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.